Cargando…

How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient’s Health)

Peritoneal dialysis (PD) is an important, if underprescribed, modality for the treatment of patients with end-stage kidney disease. Among the barriers to its wider use are the deleterious effects of currently commercially available glucose-based PD solutions on the morphological integrity and functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonomini, Mario, Masola, Valentina, Procino, Giuseppe, Zammit, Victor, Divino-Filho, José C., Arduini, Arduino, Gambaro, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347640/ https://www.ncbi.nlm.nih.gov/pubmed/34360717 http://dx.doi.org/10.3390/ijms22157955

Ejemplares similares

Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022)

A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells
por: Piccapane, Francesca, et al.
Publicado: (2020)

A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
por: Rago, Carmela, et al.
Publicado: (2021)

The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis
por: Bonomini, Mario, et al.
Publicado: (2020)

Biological Effects of XyloCore, a Glucose Sparing PD Solution, on Mesothelial Cells: Focus on Mesothelial-Mesenchymal Transition, Inflammation and Angiogenesis
por: Masola, Valentina, et al.
Publicado: (2021)

Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2019)

Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study
por: Vecchi, Luigi, et al.
Publicado: (2021)

Proteomic Research in Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2020)

Endothelial Glycocalyx as a Regulator of Fibrotic Processes
por: Masola, Valentina, et al.
Publicado: (2021)

Aquaporin-1 Facilitates Transmesothelial Water Permeability: In Vitro and Ex Vivo Evidence and Possible Implications in Peritoneal Dialysis
por: Piccapane, Francesca, et al.
Publicado: (2021)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

Survival of Peritoneal Membrane Function on Biocompatible Dialysis Solutions in a Peritoneal Dialysis Cohort Assessed by a Novel Test
por: Balafa, Olga, et al.
Publicado: (2021)

Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells
por: Bonomini, Mario, et al.
Publicado: (2016)

How microbes “jeopardize” the modern synthesis
por: Novick, Aaron, et al.
Publicado: (2019)

Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes
por: Cho, Yeoungjee, et al.
Publicado: (2012)

Is there such a thing as biocompatible peritoneal dialysis fluid?
por: Schmitt, Claus Peter, et al.
Publicado: (2016)

Peritoneal dialysis fluid biocompatibility impact on human peritoneal membrane permeability
por: Rodríguez-Esparragón, Francisco, et al.
Publicado: (2018)

Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross-over study
por: Wilflingseder, Julia, et al.
Publicado: (2009)

Biocompatible Peritoneal Dialysis: The Target Is Still Way Off
por: Bartosova, Maria, et al.
Publicado: (2019)

Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility
por: van Diepen, A.T.N., et al.
Publicado: (2020)

Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018)

Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury
por: Ponce, Daniela, et al.
Publicado: (2020)

BIOKID: Randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]
por: Nau, Barbara, et al.
Publicado: (2004)

Acetate trafficking in the heart: carnitine acyltransferases matter
por: Zammit, Victor, et al.
Publicado: (2016)

Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study
por: da Silva Fernandes, Natália Maria, et al.
Publicado: (2013)

Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events
por: Masola, Valentina, et al.
Publicado: (2018)

AQP1-Containing Exosomes in Peritoneal Dialysis Effluent As Biomarker of Dialysis Efficiency
por: Corciulo, Simone, et al.
Publicado: (2019)

Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?
por: Farhat, Karima, et al.
Publicado: (2008)

What is mutation? A chapter in the series: How microbes “jeopardize” the modern synthesis
por: Fitzgerald, Devon M., et al.
Publicado: (2019)

The breakthrough paradox: How focusing on one form of innovation jeopardizes the advancement of science
por: Falkenberg, Ruth, et al.
Publicado: (2022)

A tennis lesson: sharp practice in the science behind the Sharapova case
por: Arduini, Arduino, et al.
Publicado: (2016)

Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis
por: Smit, Watske, et al.
Publicado: (2008)

Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions
por: Kussmann, Manuel, et al.
Publicado: (2019)

Stability and compatibility of antibiotics in peritoneal dialysis solutions
por: So, Simon Wai Yin, et al.
Publicado: (2022)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

How Workplace Bullying Jeopardizes Employees’ Life Satisfaction: The Roles of Job Anxiety and Insomnia
por: Nauman, Shazia, et al.
Publicado: (2019)

A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
por: Masola, Valentina, et al.
Publicado: (2012)

Impact of heparanase on renal fibrosis
por: Masola, Valentina, et al.
Publicado: (2015)

Heparanase as active player in endothelial glycocalyx remodeling
por: Masola, Valentina, et al.
Publicado: (2021)

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions
por: Kussmann, M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kjbmrk0pfk535m03bkhabp80aa